Purchase of Own Securities

UNITED DRUG PLC

('United Drug' or 'the Company')

Purchase of Own Securities

United Drug announces that on 26 October 2011, its broker Davy purchased 20,568 Ordinary Shares of nominal value €0.05 each in the capital of the Company ("Ordinary Shares") on behalf of the Company. The price paid for these Ordinary Shares was €2.2471 per share.

This concludes the 5 million share buyback programme commenced by the Company on 24 May 2011.

The 20,568 Ordinary Shares will be cancelled. Following the cancellation of these shares, the Company's issued share capital will reduce from 238,659,701 to 238,639,133. Each Ordinary Share carries one vote. United Drug also holds 7,528,066 Ordinary Shares in treasury, which do not carry voting rights. 

Ends 27 October 2011

Contact:

Karen Geoghegan

United Drug plc

Tel: +353-1-4637720